Natural killer cells are large granular lymphocytes that respond quickly to pathological challenges.
The Natural Killer Cells Therapeutics market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025.
Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry. Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2020-2025), regional industrial layout characteristics and macroeconomic policies, industrial policy has also been included. From raw materials to end users of this industry are analyzed scientifically, the trends of product circulation and sales channel will be presented as well. Considering COVID-19, this report provides comprehensive and in-depth analysis on how the epidemic push this industry transformation and reform.
In COVID-19 outbreak, Chapter 2.2 of this report provides an analysis of the impact of COVID-19 on the global economy and the Natural Killer Cells Therapeutics industry.
Chapter 3.7 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.
In addition, chapters 7-11 consider the impact of COVID-19 on the regional economy.
The Natural Killer Cells Therapeutics market can be split based on product types, major applications, and important countries as follows:
Key players in the global Natural Killer Cells Therapeutics market covered in Chapter 12:
Cell Medica
Anhui Provincial Hospital
Baylor College of Medicine
CellProtect Nordic Pharmaceuticals
Case Comprehensive Cancer Center
Allife Medical Science and Technology
CiMass
Celularity
Cytovac
Chinese PLA General Hospital
Capital Medical University
Asan Medical Center
Catholic University of Korea
Cyto-Sen Therapeutics
In Chapter 4 and 14.1, on the basis of types, the Natural Killer Cells Therapeutics market from 2015 to 2025 is primarily split into:
NK Cell Therapies
NK Cell Directed Antibodies
In Chapter 5 and 14.2, on the basis of applications, the Natural Killer Cells Therapeutics market from 2015 to 2025 covers:
Cancer
Gastrointestinal Diseases
Immunoproliferative Disorders
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 6, 7, 8, 9, 10, 11, 14:
North America (Covered in Chapter 7 and 14)
United States
Canada
Mexico
Europe (Covered in Chapter 8 and 14)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 9 and 14)
China
Japan
South Korea
Australia
India
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 10 and 14)
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Others
South America (Covered in Chapter 11 and 14)
Brazil
Argentina
Columbia
Chile
Others
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
Table of Content
1 Natural Killer Cells Therapeutics Introduction and Market Overview
1.1 Objectives of the Study
1.2 Overview of Natural Killer Cells Therapeutics
1.3 Scope of The Study
1.3.1 Key Market Segments
1.3.2 Players Covered
1.3.3 COVID-19's impact on the Natural Killer Cells Therapeutics industry
1.4 Methodology of The Study
1.5 Research Data Source
2 Executive Summary
2.1 Market Overview
2.1.1 Global Natural Killer Cells Therapeutics Market Size, 2015 - 2020
2.1.2 Global Natural Killer Cells Therapeutics Market Size by Type, 2015 - 2020
2.1.3 Global Natural Killer Cells Therapeutics Market Size by Application, 2015 - 2020
2.1.4 Global Natural Killer Cells Therapeutics Market Size by Region, 2015 - 2025
2.2 Business Environment Analysis
2.2.1 Global COVID-19 Status and Economic Overview
2.2.2 Influence of COVID-19 Outbreak on Natural Killer Cells Therapeutics Industry Development
3 Industry Chain Analysis
3.1 Upstream Raw Material Suppliers of Natural Killer Cells Therapeutics Analysis
3.2 Major Players of Natural Killer Cells Therapeutics
3.3 Natural Killer Cells Therapeutics Manufacturing Cost Structure Analysis
3.3.1 Production Process Analysis
3.3.2 Manufacturing Cost Structure of Natural Killer Cells Therapeutics
3.3.3 Labor Cost of Natural Killer Cells Therapeutics
3.4 Market Distributors of Natural Killer Cells Therapeutics
3.5 Major Downstream Buyers of Natural Killer Cells Therapeutics Analysis
3.6 The Impact of Covid-19 From the Perspective of Industry Chain
3.7 Regional Import and Export Controls Will Exist for a Long Time
3.8 Continued downward PMI Spreads Globally
4 Global Natural Killer Cells Therapeutics Market, by Type
4.1 Global Natural Killer Cells Therapeutics Value and Market Share by Type (2015-2020)
4.2 Global Natural Killer Cells Therapeutics Production and Market Share by Type (2015-2020)
4.3 Global Natural Killer Cells Therapeutics Value and Growth Rate by Type (2015-2020)
4.3.1 Global Natural Killer Cells Therapeutics Value and Growth Rate of NK Cell Therapies
4.3.2 Global Natural Killer Cells Therapeutics Value and Growth Rate of NK Cell Directed Antibodies
4.4 Global Natural Killer Cells Therapeutics Price Analysis by Type (2015-2020)
5 Natural Killer Cells Therapeutics Market, by Application
5.1 Downstream Market Overview
5.2 Global Natural Killer Cells Therapeutics Consumption and Market Share by Application (2015-2020)
5.3 Global Natural Killer Cells Therapeutics Consumption and Growth Rate by Application (2015-2020)
5.3.1 Global Natural Killer Cells Therapeutics Consumption and Growth Rate of Cancer (2015-2020)
5.3.2 Global Natural Killer Cells Therapeutics Consumption and Growth Rate of Gastrointestinal Diseases (2015-2020)
5.3.3 Global Natural Killer Cells Therapeutics Consumption and Growth Rate of Immunoproliferative Disorders (2015-2020)
6 Global Natural Killer Cells Therapeutics Market Analysis by Regions
6.1 Global Natural Killer Cells Therapeutics Sales, Revenue and Market Share by Regions
6.1.1 Global Natural Killer Cells Therapeutics Sales by Regions (2015-2020)
6.1.2 Global Natural Killer Cells Therapeutics Revenue by Regions (2015-2020)
6.2 North America Natural Killer Cells Therapeutics Sales and Growth Rate (2015-2020)
6.3 Europe Natural Killer Cells Therapeutics Sales and Growth Rate (2015-2020)
6.4 Asia-Pacific Natural Killer Cells Therapeutics Sales and Growth Rate (2015-2020)
6.5 Middle East and Africa Natural Killer Cells Therapeutics Sales and Growth Rate (2015-2020)
6.6 South America Natural Killer Cells Therapeutics Sales and Growth Rate (2015-2020)
7 North America Natural Killer Cells Therapeutics Market Analysis by Countries
7.1 The Influence of COVID-19 on North America Market
7.2 North America Natural Killer Cells Therapeutics Sales, Revenue and Market Share by Countries
7.2.1 North America Natural Killer Cells Therapeutics Sales by Countries (2015-2020)
7.2.2 North America Natural Killer Cells Therapeutics Revenue by Countries (2015-2020)
7.3 United States Natural Killer Cells Therapeutics Sales and Growth Rate (2015-2020)
7.4 Canada Natural Killer Cells Therapeutics Sales and Growth Rate (2015-2020)
7.5 Mexico Natural Killer Cells Therapeutics Sales and Growth Rate (2015-2020)
8 Europe Natural Killer Cells Therapeutics Market Analysis by Countries
8.1 The Influence of COVID-19 on Europe Market
8.2 Europe Natural Killer Cells Therapeutics Sales, Revenue and Market Share by Countries
8.2.1 Europe Natural Killer Cells Therapeutics Sales by Countries (2015-2020)
8.2.2 Europe Natural Killer Cells Therapeutics Revenue by Countries (2015-2020)
8.3 Germany Natural Killer Cells Therapeutics Sales and Growth Rate (2015-2020)
8.4 UK Natural Killer Cells Therapeutics Sales and Growth Rate (2015-2020)
8.5 France Natural Killer Cells Therapeutics Sales and Growth Rate (2015-2020)
8.6 Italy Natural Killer Cells Therapeutics Sales and Growth Rate (2015-2020)
8.7 Spain Natural Killer Cells Therapeutics Sales and Growth Rate (2015-2020)
8.8 Russia Natural Killer Cells Therapeutics Sales and Growth Rate (2015-2020)
9 Asia Pacific Natural Killer Cells Therapeutics Market Analysis by Countries
9.1 The Influence of COVID-19 on Asia Pacific Market
9.2 Asia Pacific Natural Killer Cells Therapeutics Sales, Revenue and Market Share by Countries
9.2.1 Asia Pacific Natural Killer Cells Therapeutics Sales by Countries (2015-2020)
9.2.2 Asia Pacific Natural Killer Cells Therapeutics Revenue by Countries (2015-2020)
9.3 China Natural Killer Cells Therapeutics Sales and Growth Rate (2015-2020)
9.4 Japan Natural Killer Cells Therapeutics Sales and Growth Rate (2015-2020)
9.5 South Korea Natural Killer Cells Therapeutics Sales and Growth Rate (2015-2020)
9.6 India Natural Killer Cells Therapeutics Sales and Growth Rate (2015-2020)
9.7 Southeast Asia Natural Killer Cells Therapeutics Sales and Growth Rate (2015-2020)
9.8 Australia Natural Killer Cells Therapeutics Sales and Growth Rate (2015-2020)
10 Middle East and Africa Natural Killer Cells Therapeutics Market Analysis by Countries
10.1 The Influence of COVID-19 on Middle East and Africa Market
10.2 Middle East and Africa Natural Killer Cells Therapeutics Sales, Revenue and Market Share by Countries
10.2.1 Middle East and Africa Natural Killer Cells Therapeutics Sales by Countries (2015-2020)
10.2.2 Middle East and Africa Natural Killer Cells Therapeutics Revenue by Countries (2015-2020)
10.3 Saudi Arabia Natural Killer Cells Therapeutics Sales and Growth Rate (2015-2020)
10.4 UAE Natural Killer Cells Therapeutics Sales and Growth Rate (2015-2020)
10.5 Egypt Natural Killer Cells Therapeutics Sales and Growth Rate (2015-2020)
10.6 Nigeria Natural Killer Cells Therapeutics Sales and Growth Rate (2015-2020)
10.7 South Africa Natural Killer Cells Therapeutics Sales and Growth Rate (2015-2020)
11 South America Natural Killer Cells Therapeutics Market Analysis by Countries
11.1 The Influence of COVID-19 on Middle East and Africa Market
11.2 South America Natural Killer Cells Therapeutics Sales, Revenue and Market Share by Countries
11.2.1 South America Natural Killer Cells Therapeutics Sales by Countries (2015-2020)
11.2.2 South America Natural Killer Cells Therapeutics Revenue by Countries (2015-2020)
11.3 Brazil Natural Killer Cells Therapeutics Sales and Growth Rate (2015-2020)
11.4 Argentina Natural Killer Cells Therapeutics Sales and Growth Rate (2015-2020)
11.5 Columbia Natural Killer Cells Therapeutics Sales and Growth Rate (2015-2020)
11.6 Chile Natural Killer Cells Therapeutics Sales and Growth Rate (2015-2020)
12 Competitive Landscape
12.1 Cell Medica
12.1.1 Cell Medica Basic Information
12.1.2 Natural Killer Cells Therapeutics Product Introduction
12.1.3 Cell Medica Production, Value, Price, Gross Margin 2015-2020
12.2 Anhui Provincial Hospital
12.2.1 Anhui Provincial Hospital Basic Information
12.2.2 Natural Killer Cells Therapeutics Product Introduction
12.2.3 Anhui Provincial Hospital Production, Value, Price, Gross Margin 2015-2020
12.3 Baylor College of Medicine
12.3.1 Baylor College of Medicine Basic Information
12.3.2 Natural Killer Cells Therapeutics Product Introduction
12.3.3 Baylor College of Medicine Production, Value, Price, Gross Margin 2015-2020
12.4 CellProtect Nordic Pharmaceuticals
12.4.1 CellProtect Nordic Pharmaceuticals Basic Information
12.4.2 Natural Killer Cells Therapeutics Product Introduction
12.4.3 CellProtect Nordic Pharmaceuticals Production, Value, Price, Gross Margin 2015-2020
12.5 Case Comprehensive Cancer Center
12.5.1 Case Comprehensive Cancer Center Basic Information
12.5.2 Natural Killer Cells Therapeutics Product Introduction
12.5.3 Case Comprehensive Cancer Center Production, Value, Price, Gross Margin 2015-2020
12.6 Allife Medical Science and Technology
12.6.1 Allife Medical Science and Technology Basic Information
12.6.2 Natural Killer Cells Therapeutics Product Introduction
12.6.3 Allife Medical Science and Technology Production, Value, Price, Gross Margin 2015-2020
12.7 CiMass
12.7.1 CiMass Basic Information
12.7.2 Natural Killer Cells Therapeutics Product Introduction
12.7.3 CiMass Production, Value, Price, Gross Margin 2015-2020
12.8 Celularity
12.8.1 Celularity Basic Information
12.8.2 Natural Killer Cells Therapeutics Product Introduction
12.8.3 Celularity Production, Value, Price, Gross Margin 2015-2020
12.9 Cytovac
12.9.1 Cytovac Basic Information
12.9.2 Natural Killer Cells Therapeutics Product Introduction
12.9.3 Cytovac Production, Value, Price, Gross Margin 2015-2020
12.10 Chinese PLA General Hospital
12.10.1 Chinese PLA General Hospital Basic Information
12.10.2 Natural Killer Cells Therapeutics Product Introduction
12.10.3 Chinese PLA General Hospital Production, Value, Price, Gross Margin 2015-2020
12.11 Capital Medical University
12.11.1 Capital Medical University Basic Information
12.11.2 Natural Killer Cells Therapeutics Product Introduction
12.11.3 Capital Medical University Production, Value, Price, Gross Margin 2015-2020
12.12 Asan Medical Center
12.12.1 Asan Medical Center Basic Information
12.12.2 Natural Killer Cells Therapeutics Product Introduction
12.12.3 Asan Medical Center Production, Value, Price, Gross Margin 2015-2020
12.13 Catholic University of Korea
12.13.1 Catholic University of Korea Basic Information
12.13.2 Natural Killer Cells Therapeutics Product Introduction
12.13.3 Catholic University of Korea Production, Value, Price, Gross Margin 2015-2020
12.14 Cyto-Sen Therapeutics
12.14.1 Cyto-Sen Therapeutics Basic Information
12.14.2 Natural Killer Cells Therapeutics Product Introduction
12.14.3 Cyto-Sen Therapeutics Production, Value, Price, Gross Margin 2015-2020
13 Industry Outlook
13.1 Market Driver Analysis
13.1.2 Market Restraints Analysis
13.1.3 Market Trends Analysis
13.2 Merger, Acquisition and New Investment
13.3 News of Product Release
14 Global Natural Killer Cells Therapeutics Market Forecast
14.1 Global Natural Killer Cells Therapeutics Market Value & Volume Forecast, by Type (2020-2025)
14.1.1 NK Cell Therapies Market Value and Volume Forecast (2020-2025)
14.1.2 NK Cell Directed Antibodies Market Value and Volume Forecast (2020-2025)
14.2 Global Natural Killer Cells Therapeutics Market Value & Volume Forecast, by Application (2020-2025)
14.2.1 Cancer Market Value and Volume Forecast (2020-2025)
14.2.2 Gastrointestinal Diseases Market Value and Volume Forecast (2020-2025)
14.2.3 Immunoproliferative Disorders Market Value and Volume Forecast (2020-2025)
14.3 Natural Killer Cells Therapeutics Market Analysis and Forecast by Region
14.3.1 North America Market Value and Consumption Forecast (2020-2025)
14.3.2 Europe Market Value and Consumption Forecast (2020-2025)
14.3.3 Asia Pacific Market Value and Consumption Forecast (2020-2025)
14.3.4 Middle East and Africa Market Value and Consumption Forecast (2020-2025)
14.3.5 South America Market Value and Consumption Forecast (2020-2025)
15 New Project Feasibility Analysis
15.1 Industry Barriers and New Entrants SWOT Analysis
15.1.1 Porter's Five Forces Analysis
15.1.2 New Entrants SWOT Analysis
15.2 Analysis and Suggestions on New Project Investment
